Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.43 USD | -8.92% | -2.72% | -86.84% |
May. 08 | Earnings Flash (MRNS) MARINUS PHARMACEUTICALS Reports Q1 Revenue $7.7M, vs. Street Est of $9.1M | MT |
May. 08 | Marinus Pharmaceuticals, Inc. Increases Earnings Guidance for Full Year 2024 | CI |
Financials (USD)
Sales 2024 * | 38.73M | Sales 2025 * | 59.55M | Capitalization | 78.54M |
---|---|---|---|---|---|
Net income 2024 * | -120M | Net income 2025 * | -84M | EV / Sales 2024 * | 2.03 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.32 x |
P/E ratio 2024 * |
-0.65
x | P/E ratio 2025 * |
-1.11
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | -8.92% | ||
1 week | -2.72% | ||
Current month | +1.42% | ||
1 month | -82.56% | ||
3 months | -85.69% | ||
6 months | -79.26% | ||
Current year | -86.84% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 11 M€ | -6.03% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 1.43 | -8.92% | 2,402,294 |
24-05-07 | 1.57 | +6.08% | 1,304,147 |
24-05-06 | 1.48 | -1.99% | 1,574,489 |
24-05-03 | 1.51 | +4.14% | 1,620,694 |
24-05-02 | 1.45 | -1.36% | 989,641 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.84% | 78.54M | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+15.70% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- MRNS Stock